Question:medium
A recently diagnosed HIV-positive patient with a CD4 count of 250 cells/mm\(^3\) also tests positive for active tuberculosis. He has not yet been started on ART. What is the correct approach to initiating treatment?
A recently diagnosed HIV-positive patient with a CD4 count of 250 cells/mm\(^3\) also tests positive for active tuberculosis. He has not yet been started on ART. What is the correct approach to initiating treatment?
Show Hint
In HIV with active TB, start ATT first; then start ART early, especially when CD4 count is low.
Updated On: May 14, 2026
- Start ATT first, then initiate ART after 2 weeks
- Start ART first, then begin ATT after 2 weeks
- Start both ART and ATT simultaneously
- Start ATT first, then initiate ART after 8 weeks
Show Solution
The Correct Option is A
Solution and Explanation
Step 1: Understanding the Question:
The question addresses the clinical management of HIV and Tuberculosis (TB) co-infection.
The timing of initiating Anti-Retroviral Therapy (ART) and Anti-Tubercular Treatment (ATT) is crucial to balance the risk of mortality and the risk of Immune Reconstitution Inflammatory Syndrome (IRIS).
Step 2: Detailed Explanation:
Prioritizing TB Treatment: In any co-infection scenario, ATT must be started as soon as possible because TB is a major cause of death in HIV patients.
Guidelines for Initiation:
General Rule: Start ATT first. Then, once the patient is tolerating the TB drugs, initiate ART.
Timing based on CD4 count:
For patients with CD4 counts less than 50 $cells/mm^3$, ART should be started within 2 weeks of ATT.
For patients with CD4 counts above 50 $cells/mm^3$ (as in this case, 250 $cells/mm^3$), the standard recommendation is to start ART between 2 weeks to 8 weeks after starting ATT.
Rational for Delay: A short delay (2 weeks) helps in distinguishing between the side effects of ATT and ART and reduces the severity of IRIS, which is a paradoxical worsening of TB symptoms as the immune system recovers.
Exception: If the patient has TB meningitis, ART is usually delayed longer (6-8 weeks) due to the risk of life-threatening intracranial IRIS.
Step 3: Final Answer:
The standard approach for an HIV-TB co-infected patient with a CD4 count of 250 is to start ATT first, followed by ART after a 2-week interval.
The question addresses the clinical management of HIV and Tuberculosis (TB) co-infection.
The timing of initiating Anti-Retroviral Therapy (ART) and Anti-Tubercular Treatment (ATT) is crucial to balance the risk of mortality and the risk of Immune Reconstitution Inflammatory Syndrome (IRIS).
Step 2: Detailed Explanation:
Prioritizing TB Treatment: In any co-infection scenario, ATT must be started as soon as possible because TB is a major cause of death in HIV patients.
Guidelines for Initiation:
General Rule: Start ATT first. Then, once the patient is tolerating the TB drugs, initiate ART.
Timing based on CD4 count:
For patients with CD4 counts less than 50 $cells/mm^3$, ART should be started within 2 weeks of ATT.
For patients with CD4 counts above 50 $cells/mm^3$ (as in this case, 250 $cells/mm^3$), the standard recommendation is to start ART between 2 weeks to 8 weeks after starting ATT.
Rational for Delay: A short delay (2 weeks) helps in distinguishing between the side effects of ATT and ART and reduces the severity of IRIS, which is a paradoxical worsening of TB symptoms as the immune system recovers.
Exception: If the patient has TB meningitis, ART is usually delayed longer (6-8 weeks) due to the risk of life-threatening intracranial IRIS.
Step 3: Final Answer:
The standard approach for an HIV-TB co-infected patient with a CD4 count of 250 is to start ATT first, followed by ART after a 2-week interval.
Was this answer helpful?
0
